Omnicell Stock Net Income
| OC9 Stock | EUR 34.00 1.40 4.29% |
As of the 21st of February, Omnicell holds the Coefficient Of Variation of 1424.49, semi deviation of 4.2, and Risk Adjusted Performance of 0.0615. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Omnicell, as well as the relationship between them. Please check Omnicell jensen alpha, maximum drawdown, and the relationship between the information ratio and treynor ratio to decide if Omnicell is priced some-what accurately, providing market reflects its current price of 34.0 per share.
Omnicell Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization 1.6 B | Enterprise Value Revenue 1.4593 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Income From Continuing Ops | 11.3 M | 21 M | |
| Net Income Applicable To Common Shares | 6.5 M | 6.2 M | |
| Net Income | 11.3 M | 21.8 M |
Omnicell | Net Income |
The Net Income trend for Omnicell offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Omnicell is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Omnicell's Net Income Growth Pattern
Below is the plot of the Net Income of Omnicell over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Omnicell financial statement analysis. It represents the amount of money remaining after all of Omnicell operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Omnicell's Net Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Omnicell's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 12.53 M | 10 Years Trend |
|
Net Income |
| Timeline |
Omnicell Net Income Regression Statistics
| Arithmetic Mean | 26,105,968 | |
| Coefficient Of Variation | 85.11 | |
| Mean Deviation | 15,458,861 | |
| Median | 30,518,000 | |
| Standard Deviation | 22,218,833 | |
| Sample Variance | 493.7T | |
| Range | 98.2M | |
| R-Value | (0.24) | |
| Mean Square Error | 496.8T | |
| R-Squared | 0.06 | |
| Significance | 0.36 | |
| Slope | (1,046,836) | |
| Total Sum of Squares | 7898.8T |
Omnicell Net Income History
Omnicell 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Omnicell's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Omnicell.
| 11/23/2025 |
| 02/21/2026 |
If you would invest 0.00 in Omnicell on November 23, 2025 and sell it all today you would earn a total of 0.00 from holding Omnicell or generate 0.0% return on investment in Omnicell over 90 days. Omnicell is related to or competes with Cass Information, Data#3, CPU SOFTWAREHOUSE, Alibaba Health, Science Applications, AXWAY SOFTWARE, and Information Services. Omnicell, Inc. provides medication and supply dispensing automation, central pharmacy automation, analytics software, an... More
Omnicell Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Omnicell's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Omnicell upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.62 | |||
| Information Ratio | 0.0488 | |||
| Maximum Drawdown | 28.03 | |||
| Value At Risk | (3.70) | |||
| Potential Upside | 6.44 |
Omnicell Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Omnicell's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Omnicell's standard deviation. In reality, there are many statistical measures that can use Omnicell historical prices to predict the future Omnicell's volatility.| Risk Adjusted Performance | 0.0615 | |||
| Jensen Alpha | 0.2094 | |||
| Total Risk Alpha | (0.09) | |||
| Sortino Ratio | 0.0397 | |||
| Treynor Ratio | 0.3997 |
Omnicell February 21, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0615 | |||
| Market Risk Adjusted Performance | 0.4097 | |||
| Mean Deviation | 2.32 | |||
| Semi Deviation | 4.2 | |||
| Downside Deviation | 4.62 | |||
| Coefficient Of Variation | 1424.49 | |||
| Standard Deviation | 3.76 | |||
| Variance | 14.16 | |||
| Information Ratio | 0.0488 | |||
| Jensen Alpha | 0.2094 | |||
| Total Risk Alpha | (0.09) | |||
| Sortino Ratio | 0.0397 | |||
| Treynor Ratio | 0.3997 | |||
| Maximum Drawdown | 28.03 | |||
| Value At Risk | (3.70) | |||
| Potential Upside | 6.44 | |||
| Downside Variance | 21.38 | |||
| Semi Variance | 17.66 | |||
| Expected Short fall | (2.52) | |||
| Skewness | (2.34) | |||
| Kurtosis | 13.65 |
Omnicell Backtested Returns
Omnicell appears to be very steady, given 3 months investment horizon. Omnicell maintains Sharpe Ratio (i.e., Efficiency) of 0.0542, which implies the firm had a 0.0542 % return per unit of risk over the last 3 months. We have found thirty technical indicators for Omnicell, which you can use to evaluate the volatility of the company. Please evaluate Omnicell's Semi Deviation of 4.2, coefficient of variation of 1424.49, and Risk Adjusted Performance of 0.0615 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Omnicell holds a performance score of 4. The company holds a Beta of 0.64, which implies possible diversification benefits within a given portfolio. As returns on the market increase, Omnicell's returns are expected to increase less than the market. However, during the bear market, the loss of holding Omnicell is expected to be smaller as well. Please check Omnicell's jensen alpha, sortino ratio, maximum drawdown, as well as the relationship between the total risk alpha and treynor ratio , to make a quick decision on whether Omnicell's historical price patterns will revert.
Auto-correlation | -0.66 |
Very good reverse predictability
Omnicell has very good reverse predictability. Overlapping area represents the amount of predictability between Omnicell time series from 23rd of November 2025 to 7th of January 2026 and 7th of January 2026 to 21st of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Omnicell price movement. The serial correlation of -0.66 indicates that around 66.0% of current Omnicell price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.66 | |
| Spearman Rank Test | -0.78 | |
| Residual Average | 0.0 | |
| Price Variance | 21.66 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Omnicell Operating Income
Operating Income |
|
Based on the recorded statements, Omnicell reported net income of 12.53 M. This is 97.68% lower than that of the Health Care Technology sector and 70.18% lower than that of the Health Care industry. The net income for all Germany stocks is 97.81% higher than that of the company.
Omnicell Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Omnicell's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Omnicell could also be used in its relative valuation, which is a method of valuing Omnicell by comparing valuation metrics of similar companies.Omnicell is currently under evaluation in net income category among its peers.
Omnicell Fundamentals
| Return On Equity | 0.0017 | ||||
| Return On Asset | 0.003 | ||||
| Profit Margin | 0 % | ||||
| Operating Margin | 0.01 % | ||||
| Current Valuation | 1.46 B | ||||
| Shares Outstanding | 44.88 M | ||||
| Shares Owned By Insiders | 1.82 % | ||||
| Shares Owned By Institutions | 98.18 % | ||||
| Price To Earning | 81.37 X | ||||
| Price To Book | 1.41 X | ||||
| Price To Sales | 1.33 X | ||||
| Revenue | 1.11 B | ||||
| Gross Profit | 508.04 M | ||||
| EBITDA | 88.56 M | ||||
| Net Income | 12.53 M | ||||
| Cash And Equivalents | 77.24 M | ||||
| Cash Per Share | 1.87 X | ||||
| Total Debt | 174.32 M | ||||
| Debt To Equity | 22.50 % | ||||
| Current Ratio | 1.96 X | ||||
| Book Value Per Share | 23.28 X | ||||
| Cash Flow From Operations | 187.72 M | ||||
| Earnings Per Share | 0.03 X | ||||
| Target Price | 167.5 | ||||
| Number Of Employees | 3.6 K | ||||
| Beta | 0.77 | ||||
| Market Capitalization | 1.57 B | ||||
| Total Asset | 2.12 B | ||||
| Retained Earnings | 382.89 M | ||||
| Working Capital | 219.81 M | ||||
| Net Asset | 2.12 B |
About Omnicell Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Omnicell's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Omnicell using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Omnicell based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Omnicell. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation. For more detail on how to invest in Omnicell Stock please use our How to Invest in Omnicell guide.You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.